Cidara Therapeutics
CDTX
CDTX
42 hedge funds and large institutions have $90M invested in Cidara Therapeutics in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-12
Holders Change %
-22.22%
% of All Funds
1.05%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
1
Increased
14
Reduced
11
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.04M |
2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$1.88M |
3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.16M |
4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$203K |
5 |
Squarepoint
New York
|
+$167K |
Top Sellers
1 |
PVI
Pura Vida Investments
New York
|
-$1.13M |
2 |
Goldman Sachs
New York
|
-$650K |
3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$492K |
4 |
PA
Perceptive Advisors
New York
|
-$465K |
5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$353K |